Low levels of high density lipoprotein cholesterol in Turkish children: An important risk factor

Acta Paediatrica Japonica (Overseas Edition)

Volumn 40, Issue 1, 1998, Pages 41-46

  Işcan, Akin ^a,b   Yiǧitoǧlu, M Ramazan ^a   Vurgun, Nureddin ^a   Uyanik, B Sami ^a   Akyildiz, Muhittin ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Children; Lipids; Lipoproteins

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; AGE; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION FUNCTION; DYSLIPIDEMIA; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

ADOLESCENT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; RISK FACTORS; TRIGLYCERIDES; TURKEY;

EID: 0031911989     PISSN: 03745600     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89:1329-445.
2. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Harvard University Press. Cambridge, MA, 1980.
3. Stamler J, Wenworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous? (Graded findings in 356 222 primary screenecs of the Multiple Risk Factor Intervention Trial (MRFIT)). JAMA 1986; 256: 2823-8.
4. Anderson KW, Castelli WP, Levy D. Cholesterol and mortality: 30 years follow-up from The Framingham Study. JAMA 1987; 257: 2176-80.
5. Jacobs D, Blackburn M, Higgins M et al. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation 1992; 86: 1046-60.
6. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am. J. Med. 1977; 62: 707-14.
7. Watkins LO, Neaton JD, Kuller LH. Racial differences in high density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial. Am. J. Cardiol. 1986; 57: 538-45.
8. Gordon DJ, Probstfield JL, Garrison RJ et al. High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation 1989; 79: 8-15.
9. Corti MC, Guralnik JM, Salive ME et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995; 274: 539-44.
10. Drash A. Atherosclerosis, cholesterol and pediatrician. J. Pediatr. 1972; 80: 693-6.
11. Stare T, Deckelbaum RJ. Evaluation of hypercholesterolemia in childhood, Pediatr. Rev. 1996; 17: 94-7.
12. Gonzalez-Requejo A, Sanchez-Bayle M, Baeza J et al. Relation between nutrient intake and serum lipid and apolipoprotein levels. J. Pediatr. 1995; 127: 53-7.
13. İşcan A, Uyanik BS, Vurgun N, Ece A, Yiǧitoǧlu MR. Effects of passive exposure to tobacco, socioeconomic status and a family history of essential hypertension on lipid profiles in children. Jpn Heart J. 1996; 37: 917-23.
14. Friedwald W, Levy R, Frederickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 172; 18: 499-502.
15. Knuiman JT, Hermus RJ, Hautvast JG. Serum total and high density lipoprotein (HDL) cholesterol concentrations in rural and urban boys from 16 countries. Atherosclerosis. 1980; 36: 529-37.
16. Frerichs RR, Srinivasan SR, Webber LS, Berenson GR. Serum cholesterol and triglyceride levels in 3446 children from a biracial community: the Bogalusa Heart Study. Circulation. 1976; 54: 302-9.
17. Christensen B, Glueck C, Kwiterovich P et al. Plasma cholesterol and triglyceride distributions in 13 665 children and adolescents: the Prevalence Study of the Lipid Research Clinics Program. Pediatr Res. 1980; 14: 194-202.
18. Wajid Ali S, Buch NA, Masood H. Serum lipid profile in Kashmiri children. Indian J. Physiol. Pharmacol. 1995; 39: 55-8.
19. Gomez Gerique JA, Porres A, Loges Marninez D et al. Levels of lipoprotein(a) and plasma lipids in Spanish children aged from 4 to 18 years. Acta Paediatr. 1996; 85: 38-42.
20. Okada T, Sato Y, Yamazaki T et al. Lipoprotein(a) and apolipoprotein A-1 and B in school children whose grandparents had coronary and cerebrovascular events: A preliminary study of 12-13 years old Japanese children. Acta Paediatr Jpn. 1995; 37: 582-7.
21. Boulton TJC, Magarey AM, Cockington RA. Serum lipids and apolipoproteins from 1 to 15 years: changes with ages and puberty, and family history at ischemic heart disease. Acta Paediatr. 1995; 84: 1113-18.
22. Badruddin SH, Molla A, Khursheed M, Vaz S, Hassanali S. Cardiovascular risk factors in school children from low middle income families in Karachi, Pakistan. J. Pakistan Med. Assoc. 1994; 44: 106-12.
23. National Cholesterol Education Program (NCEP). Highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89: 495-500.
24. Lipid Research Clinics Program Epidemiology Committee: Plasma lipid distributions in selected North American population: Lipid Research Clinics program Prevalence Study. Circulation 1979; 60: 427-39.
25. Warnick GR, Cheung MC, Albers JJ. Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin. Chem. 1979; 25: 596-604.
26. Mahley RW, Palaoglu KE, Atak Z et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J. Lipid Res. 1995; 36: 839-59.
27. Johnson CL, Rifkind BM, Sempos CT et al. Declining serum total cholesterol levels among US adults: The National Health and Nutrition Examination Surveys. JAMA 1993; 269: 3002-8.
28. Lüttmann S, Von Eckardstein A, Wei W et al. Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III (Asp45 -Asn), in a Turkish patient. J. Lipid Res. 1994; 35: 1431-40.
29. Goldbourt U, Yaari A, Cohen-Mandelzweig L et al. High-density lipoprotein cholesterol correlation with biochemical, arthropometric, behavioural and clinic parametry in 6500 Israeli men. Prev. Med. 1986; 15: 569-81.
30. Glueck CF, Taylor HL, Jacobs D et al. Plasma high-density lipoprotein cholesterol association with measurements of body mass. The lipid research clinics program study. Circulation 1982; 62: 62-9.
31. Dahlstrom S, Viikari J, Akerblom HK et al. Atherosclerosis precursors in Finnish children and adolescents. II. Height, weight, body mass index, and skinfolds, and their correlation to metabolic variables. Acta Paediatr. Scänd. 1985; 18 (Suppl. 3): 65-78.
32. Sallis JF, Petterson TL, Buono MJ, Nader PR. Relation of cardiovascular fitness and physical activity to cardiovascular disease risk factors in children and adults. Am. J. Epidemiol. 1988; 127: 933-41.
33. Castelli WP. Epidemiology of coronary heart disease: The Framingham Study. Am. J. Med. 1984; 76 (Suppl. 2A): 4-12.
34. Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983; 67: 730-4.
35. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalouadian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 1985; 256: 2835-8.
36. Castelli WP. The folly of questioning the benefits of cholesterol reduction. Am. Fam. Physician. 1994; 49: 567-74.
37. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am. J. Cardiol. 1992; 70: 733-7.
38. Manninen V, Tenkanen L, Koskinen J et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992; 85: 37-45.
39. Webber LSS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: The Bogalusa Heart Study. Am. J. Epidemiol. 1991; 133: 884-99.
40. Strong JP. The natural history of atherosclerosis in childhood. In: Williams CL, Wynder EL (eds). Hyperlipidemia in Childhood and the Development of Atherosclerosis, Vol. 623. Annals of the New York Academy of Sciences, New York, 1991; 9-15.
41. Hostetter AL. Screening for dyslipidemia: Practice parameter. Am. J. Clin. Pathol. 1995; 103: 380-5.